Transcatheter aortic valve implantation in a lung transplant recipient

Anne-Kathrin Brill; Steffen Gloekler; John-David Aubert; Peter M Wenaweser; Thomas Geiser

doi:10.1016/j.athoracsur.2014.01.022

Transcatheter aortic valve implantation in a lung transplant recipient

Ann Thorac Surg. 2014 Jun;97(6):e159-60. doi: 10.1016/j.athoracsur.2014.01.022.

Authors

Anne-Kathrin Brill¹, Steffen Gloekler², John-David Aubert³, Peter M Wenaweser², Thomas Geiser⁴

Affiliations

¹ Department of Pulmonary Medicine, University Hospital and University of Bern, Bern, Switzerland; Academic Department of Sleep and Breathing, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom. Electronic address: [email protected].
² Cardiology, Cardiovascular Department, University Hospital and University of Bern, Bern, Switzerland.
³ Service de Pneumologie et Centre Transplantation, University Hospital and University of Lausanne, Lausanne, Switzerland.
⁴ Department of Pulmonary Medicine, University Hospital and University of Bern, Bern, Switzerland.

PMID: 24882332
DOI: 10.1016/j.athoracsur.2014.01.022

Abstract

Transcatheter aortic valve implantation is a feasible therapeutic option for selected patients with severe aortic stenosis and high or prohibitive risk for standard surgery. Lung transplant recipients are often considered high-risk patients for heart surgery because of their specific transplant-associated characteristics and comorbidities. We report a case of successful transfemoral transcatheter aortic valve replacement in a lung transplant recipient with a symptomatic severe aortic stenosis, severe left ventricular dysfunction, and end-stage renal failure 9 years after bilateral lung transplantation.

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Aortic Valve / surgery*
Aortic Valve Stenosis / surgery*
Cardiac Catheterization
Heart Valve Prosthesis Implantation*
Humans
Lung Transplantation*
Male
Middle Aged